ERBB2 and breast cancer: The most common genetic alterations in human BC samples from SNUH were TP53 mutations (82.3%), ERBB2 amplifications (56.3%), CDK12 amplifications (43.8%), MYC amplifications (37.5%), and CDKN2A/2B copy number loss (37.5%) (Fig. 1C, Sup.